| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $7.3M+1181.3% | $566K+44.4% | $392K-73.9% | $1.5M |
| Research and development | $25.6M-30.4% | $36.8M+28.6% | $28.6M+16.1% | $24.6M |
| General and administrative | $24.1M-6.1% | $25.7M-17.4% | $31.1M-4.2% | $32.4M |
| Total operating expenses | $49.7M-20.4% | $62.5M+4.7% | $59.7M+4.6% | $57.1M |
| Loss from operations | -$42.4M+31.4% | -$61.9M-4.4% | -$59.3M-6.7% | -$55.5M |
| Other income (expense), net | $25.0M-29.4% | $35.5M+410.6% | $6.9M+403.4% | $1.4M |
| Loss before provision for income taxes | -$17.4M+34.1% | -$26.4M+49.5% | -$52.3M+3.4% | -$54.2M |
| Provision for income taxes | $0 | $0 | $0 | $0 |
| Net loss | -$17.4M+34.1% | -$26.4M+49.5% | -$52.3M+3.4% | -$54.2M |
| Series A Preferred Stock | ||||
| Net loss per share, basic (in dollars per share) | -$230.00+37.8% | -$370.00+99.9% | -$728640.00-94628471.4% | -$0.77 |
| Net loss per share, diluted (in dollars per share) | -$230.00+37.8% | -$370.00+99.9% | -$728640.00-94628471.4% | -$0.77 |
| Weighted-average common shares outstanding, basic (in shares) | 73.74B+4.0% | 70.91B+5672333.8% | 1.3M-98.2% | 70.4M |
| Weighted-average common shares outstanding, diluted (in shares) | 73.74B+4.0% | 70.91B+0.5% | 70.58B+100121.2% | 70.4M |
| Common Stock | ||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.